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Lamour et al. (2014) recently suggested a link between gut microbiome and Leishmania 
infection in mice. They showed that in two different mouse models of cutaneous 
leishmaniasis, susceptible or self-healing models, with the progression of the infection 
also the fecal microbiome changed, with Clostridia class higher in the first group and 
Gammaproteobacteria classes higher in the second one, suggesting that the intestinal 
microbial composition could be linked to a different response to the disease. 
Aim of the work: In this study we investigated the main fecal bacterial groups in dogs 
positive for Leishmania spp., with the aim of evaluating possible differences between 
enrolled dogs. Materials and methods: Naturally voided fecal samples were collected from 
8 dogs resulted positive (exposed, infected or sick) for leishmaniasis by IFAT or ELISA 
(dog no. 4). In most cases dogs differed for IFAT titers and for time elapsed between 
positivity detection and samples collection. Five dogs (2-4, 6, 8) were not presenting any 
concomitant disease and were not undergoing any treatment. Four dogs (2, 3, 6, 7) were 
not symptomatic at the time of fecal sampling; only one dog (4) was undergoing therapy 
for leishmaniosis at the time of fecal sampling, and 4 dogs (2, 6-8) had been previously 
treated for the disease, while for the remaining three it was a first diagnosis. The samples 
were frozen briefly after collection. All dogs were fed on commerce diet, with the addiction 
 n  o  n 1 of  ook   ―p st ‖  n  m  t    R  l-Time quantitative PCR (qPCR) procedure 
was used for the quantification of the main bacterial groups of intestinal microbiota by 
using specif   pr m rs  s r port    y N sut   t  l   2 16   DN  w s  xtr  t   from  o s‘ 
fecal samples using Stool DNA isolation kit (Norgen, Thorold, Canada). Bifidobacterium 
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spp., Bacteroides-Prevotella-Porphyromonas spp., Clostridium coccoides-Eubacterium 
rectale group, Enterobacteriaceae, Lactobacillus spp. and Staphylococcus spp. were 
quantified using a Mx3000P Real Time PCR based on SYBR Green detection.  
The more represented group in all dogs was Clostridium coccoides-Eubacterium rectale 
group with a mean value of 3.4x109 CFU/g of feces, while Lactobacillus spp. was the less 
present with a mean value of 3.6x103 CFU/g of feces. The ongoing therapy at the 
sampling time seemed to affect (not significantly) the log values of Clostridium coccoides-
Eubacterium rectale group and Lactobacillus spp. that both were higher in the treated dog 
(4) compared to the mean log values of those untreated. 
To t    ut ors‘ knowl     t  s  s t   f rst stu y on p t  nts pos t v  for l  s m n  s s 
with these selected fecal bacterial groups. Even if it presents some limitations (small 
number of dogs, great variability within the variables), it would be interesting to deepen 
the possible correlation between leishmaniasis and the intestinal microbiota in the dogs 
suffered from this disease. 
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